These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8315466)

  • 21. Optic gliomas in neurofibromatosis type 1 (NF-1). Presentation of 31 cases.
    Pascual-Castroviejo I; Martínez Bermejo A; López Martín V; Roche C; Pascual Pascual SI
    Neurologia; 1994 May; 9(5):173-7. PubMed ID: 8024821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolated optic nerve gliomas in children with and without neurofibromatosis.
    Duffner PK; Cohen ME
    Neurofibromatosis; 1988; 1(4):201-11. PubMed ID: 3152472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Moya-Moya syndrome after cranial radiation for optic glioma with NF1. Case report and literature review of syndromic cases.
    Brandicourt P; Bonnet L; Béjot Y; Drouet C; Moulin T; Thines L
    Neurochirurgie; 2018 Mar; 64(1):63-67. PubMed ID: 29475609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation-Induced Moyamoya Syndrome after Proton Beam Therapy in the Pediatric Patient: A Case Series.
    Reynolds MR; Haydon DH; Caird J; Leonard JR
    Pediatr Neurosurg; 2016; 51(6):297-301. PubMed ID: 27193755
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optic nerve gliomas in children: a reappraisal.
    West CG
    Br J Neurosurg; 1987; 1(1):99-104. PubMed ID: 3267282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An association between optic glioma and other tumours of the central nervous system in neurofibromatosis type 1.
    Friedman JM; Birch P
    Neuropediatrics; 1997 Apr; 28(2):131-2. PubMed ID: 9208416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence and long-term outcome of postradiotherapy moyamoya syndrome in pediatric patients with primary brain tumors: a single institute experience in Taiwan.
    Wu YH; Chang FC; Liang ML; Chen HH; Wong TT; Yen SH; Chen YW
    Cancer Med; 2016 Aug; 5(8):2155-60. PubMed ID: 27265024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Optic pathway gliomas in patients with neurofibromatosis type 1: clinical-neuroradiological integrated approach].
    Zuccoli G; Ferrozzi F; Signorini M; Virdis R; Troiso A
    Radiol Med; 2001 May; 101(5):382-5. PubMed ID: 11438792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of asymptomatic moyamoya arteriopathy in pediatric syndromic populations: radiographic and clinical progression.
    Lin N; Baird L; Koss M; Kopecky KE; Gone E; Ullrich NJ; Scott RM; Smith ER
    Neurosurg Focus; 2011 Dec; 31(6):E6. PubMed ID: 22133171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Optic glioma in 3 patients with Recklinghausen disease].
    Moro F; Cavallaro N
    Klin Monbl Augenheilkd; 1995 Mar; 206(3):178-83. PubMed ID: 7616728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Optic glioma in children with type 1 neurofibromatosis].
    Ben-Arush M; Goldberg H; Kuten A; Guilbord J; el-Hassid R
    Harefuah; 1998 Oct; 135(7-8):264-7, 336. PubMed ID: 9885670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas.
    Chang L; El-Dairi MA; Frempong TA; Burner EL; Bhatti MT; Young TL; Leigh F
    J AAPOS; 2010 Dec; 14(6):511-7. PubMed ID: 21168074
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Moyamoya syndrome in children with neurofibromatosis type 1: Italian-French experience.
    Santoro C; Di Rocco F; Kossorotoff M; Zerah M; Boddaert N; Calmon R; Vidaud D; Cirillo M; Cinalli G; Mirone G; Giugliano T; Piluso G; D'Amico A; Capra V; Pavanello M; Cama A; Nobili B; Lyonnet S; Perrotta S
    Am J Med Genet A; 2017 Jun; 173(6):1521-1530. PubMed ID: 28422438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Visual loss despite anticoagulation in radiation-induced optic neuropathy.
    Danesh-Meyer HV; Savino PJ; Sergott RC
    Clin Exp Ophthalmol; 2004 Jun; 32(3):333-5. PubMed ID: 15180850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Akin moyamoya disease in children].
    Inoue T; Matsushima T; Fujii K; Fukui M; Hasuo K; Matsuo H
    No Shinkei Geka; 1993 Jan; 21(1):59-65. PubMed ID: 8426689
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrovascular abnormalities in a population of children with neurofibromatosis type 1.
    Rosser TL; Vezina G; Packer RJ
    Neurology; 2005 Feb; 64(3):553-5. PubMed ID: 15699396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vascular collateralization along ventriculoperitoneal shunt catheters in moyamoya disease.
    Singla A; Lin N; Ho AL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2013 Jun; 11(6):710-2. PubMed ID: 23581637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follow-up of optic pathway gliomas in children with neurofibromatosis type 1.
    Kuenzle C; Weissert M; Roulet E; Bode H; Schefer S; Huisman T; Landau K; Boltshauser E
    Neuropediatrics; 1994 Dec; 25(6):295-300. PubMed ID: 7770126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P; Opocher E; Pinello ML; Calderone M; Viscardi E; Clementi M; Battistella PA; Laverda AM; Da Dalt L; Perilongo G
    Neuro Oncol; 2007 Oct; 9(4):430-7. PubMed ID: 17704361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence of optic pathway gliomas after previously negative neuroimaging.
    Massry GG; Morgan CF; Chung SM
    Ophthalmology; 1997 Jun; 104(6):930-5. PubMed ID: 9186431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.